Quick Answer
BIOLIFE SOLUTIONS INC reported Long Term Debt of $0.00 for the year ending 2025.
- BIOLIFE SOLUTIONS INC showed a decrease of -100.0% in Long Term Debt from 2024 to 2025.
- This data is from BIOLIFE SOLUTIONS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $5.02 million | Q3 2021: $6.12 million | Q1 2022: $6.31 million | Q2 2022: $6.19 million | Q3 2022: $24.21 million | Q1 2023: $23.69 million | Q2 2023: $23.57 million | Q3 2023: $20.94 million | Q1 2024: $15.68 million | Q2 2024: $10.45 million | Q3 2024: $7.82 million | Q1 2025: $2.50 million | Q2 2025: $0.00 | Q3 2025: $0.00.
- Over the full 6 years of available data (2020 to 2025), BIOLIFE SOLUTIONS INC's Long Term Debt has declined by 100.0%.
- Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2024: $5.00 million | Fiscal year 2023: $17.56 million | Fiscal year 2022: $23.79 million | Fiscal year 2021: $6.35 million | Fiscal year 2020: $655.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: